Stockreport

Positive Partial 12-Week Blood Sugar Results from Lexaria's GLP-1 Diabetes Animal Study [Yahoo! Finance]

Lexaria Bioscience Corp.  (LEXX) 
PDF KELOWNA, BC / ACCESSWIRE / October 24, 2024 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery pla [Read more]